By the close of trading, Tempus AI's stock price was up more than 4% after rising as much as 15% earlier in the day. Tempus ...

Tempus and NYU Langone Health have formed a multi-year strategic collaboration to advance cancer research through molecular profiling and data-driven insights. The partnership will support NYU Langone ...

Northwestern Medicine and Tempus AI, Inc. (NASDAQ: TEM) are collaborating to expand access to genomic testing for ...

Tempus, a leader in artificial intelligence and precision medicine, and NYU Langone Health, one of the nation's premier academic medical centers, today announced a multi-year strategic collaboration ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that eight abstracts have been accepted for presentation at the 2026 ASCO ...

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the Morgan Stanley Technology, ...

Tempus AI Inc., a provider of medical testing services and clinical software, closed its first day of trading with its stock price up 8.7%. The company floated its shares on the Nasdaq this morning ...

Get the live share price of Tempus AI, Inc. Class A Common Stock (TEM), including intraday charts, historical performance, ...

Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest since its successful IPO in June 2024. The stock had been on a strong upward ...

Tempus AI provides an end-to-end diagnostic platform connecting clinical, molecular, and image data for physicians and pharmaceutical companies. The company's key competitive advantages include broad ...

Tempus AI Inc. is about to give investors a way to play the intersection of medicine and artificial intelligence. The healthcare-technology company, founded in 2015, plans to offer 11.1 million shares ...